xcovery.blogspot.com
Xcovery blog - kinase industry knowledge collected and sometimes analyzed: Tarceva: running in place?
http://xcovery.blogspot.com/2007/01/tarceva-running-in-place.html
Xcovery blog - kinase industry knowledge collected and sometimes analyzed. Wednesday, January 24, 2007. Tarceva: running in place? One other note from the DNA earnings numbers: Tarceva sales grew 27% year over year and 7% sequentially (total: $107M). Very bad news for OSI. DNA is more motivated to push Avastin for solid tumors, so Tarceva is probably undermarketed by something between $500M and $1B. Subscribe to: Post Comments (Atom). Kinase Industry Biz News. Guide to biotech IP. IHOP - great protein db.
lucasmembrane.livejournal.com
Hahahahahahahahaha - Zen and the Art of LiveJournal
http://lucasmembrane.livejournal.com/308679.html
Hahahahahahahahaha - Zen and the Art of LiveJournal. Chinese Food Mind Games. 02:51 pm March 6th, 2010. So Amber found an interesting chemist position with the Navy, and I went to apply for it. I gotta say, their security measures don't exactly fill me with confidence. Not only is their security certificate invalid, their password requirements are as follows:. Good job there, guys. Actually, turns out they only email you the password hint, so that's something. Or Leave a comment. Thread started by Nate.
syntheticenvironment.blogspot.com
A Synthetic Environment: Birthday...
http://syntheticenvironment.blogspot.com/2007/11/birthday.html
Wednesday, November 14, 2007. 1 year old, 139 posts, 50K visitors, top 5 lists, beards and dead chemists.Hooray! Superb, Well done. keep up the good work. November 14, 2007 at 3:51:00 PM GMT 1. Well, it looks like you struggled a little bit lately to post something.however, cogratulations, you have one of the most original and entertaining blogs I've ever seen, I can just sing you "Happy Birthday! Very loudly and hope you'll keep posting. Well done! November 14, 2007 at 3:57:00 PM GMT 1. A Zephyr in Time.
hetchem.blogspot.com
Heterocyclic Chemistry: février 2007
http://hetchem.blogspot.com/2007_02_01_archive.html
Vendredi 16 février 2007. Synthesis of 2,3-Dihydro-pyrrolopyridinones. Recently, Bischoff et al. has described the synthesis of 2,3-Dihydropyrrolopyridinone by a tandem aminomethylation-Cyclization using in situ generated formimine and an ortho-lithiated pyridinecarboxamide, depending on the reaction conditions it is also possible to continue the cascade reaction with a bis alkylation of the pyrrolidinone ring. Jeudi 15 février 2007. Cyclization was attempted with para. Mardi 13 février 2007. The post of...
syntheticenvironment.blogspot.com
A Synthetic Environment: The rise and fall of rimonabant
http://syntheticenvironment.blogspot.com/2007/11/rise-and-fall-of-rimonabant.html
Monday, November 26, 2007. The rise and fall of rimonabant. The rise and fall of SR141716A/rimonabant/Acomplia/Zimulti. A good game website for age of conan. And Age Of Conan gold. September 29, 2008 at 7:47:00 AM GMT 2. Subscribe to: Post Comments (Atom). Een of andere vent and Snaack syntheticenvironment{at}gmail.com. View my complete profile. A Chemist's Laboratory Notebook. A Zephyr in Time. Distillations blog (Chemical Heritage Foundation). One in ten thousand. Org prep. daily.
syntheticenvironment.blogspot.com
A Synthetic Environment: Bottle of wine, fruit of the vine
http://syntheticenvironment.blogspot.com/2007/12/bottle-of-wine-fruit-of-vine.html
Tuesday, December 18, 2007. Bottle of wine, fruit of the vine. Do you like wine? An alarming title of a paper. By Harry Drake Gibbs (1872 – 1934). This is the guy from gibbs reagent (2,6-dichloroquinonechloroimide for a phenol test, Chem. Rev. 1927, 3, 291. The arsenic in the wine came from arsenic-containing pesticides, clarifying agents, aniline-dyes and agents to clean the wine casks. You may think: ‘I don’t care I prefer beer.’ Well don’t feel safe. I shouldn't be using arsenic in my brewing? By Davi...
xcovery.blogspot.com
Xcovery blog - kinase industry knowledge collected and sometimes analyzed: A couple of extra thoughts from 2006
http://xcovery.blogspot.com/2007/02/couple-of-extra-thoughts-from-2006.html
Xcovery blog - kinase industry knowledge collected and sometimes analyzed. Thursday, February 22, 2007. A couple of extra thoughts from 2006. Anybody else surprised that Iressa racked up nearly a quarter billion in revenue? I thought AZ was just maintaining Iressa in the hopes that biomarker/personalized medicine research would fully characterize responders with significant sales to come only after conclusive studies, but Iressa is still achieving good levels of revenue. And actual sales (? Welcome to ou...
xcovery.blogspot.com
Xcovery blog - kinase industry knowledge collected and sometimes analyzed: Why drugs fall short in late-stage trials
http://xcovery.blogspot.com/2007/01/why-drugs-fall-short-in-late-stage.html
Xcovery blog - kinase industry knowledge collected and sometimes analyzed. Wednesday, January 24, 2007. Why drugs fall short in late-stage trials. Kick-ass article from McKinsey reviewing why drugs fail in P3, based on 650 small molecule trials since 1990. Over all diseases, 42% of leads failed P3, slightly worse than most models anticipate. (The Milken Model. Anticipates a 33% failure rate at this stage for small molecules.). Quantitative endpoints (biomarkers) improve the likelihood of P3 success.
xcovery.blogspot.com
Xcovery blog - kinase industry knowledge collected and sometimes analyzed: Sutent now a first line therapy for RCC in Europe
http://xcovery.blogspot.com/2007/01/sutent-now-first-line-therapy-for-rcc.html
Xcovery blog - kinase industry knowledge collected and sometimes analyzed. Thursday, January 18, 2007. Sutent now a first line therapy for RCC in Europe. I found some information about SUTENT. Subscribe to: Post Comments (Atom). Kinase Industry Biz News. Guide to biotech IP. IHOP - great protein db. Seeking Alpha - solid biotech investment insight. Decent but dated summary of kinase therapeutics. Org Prep Daily (home of Milkshake). Whistling in the Wind. Kinase efforts you may not know of.